Get started
Author

Xiangshun Kong

Observed name: Fan-lei Kong
ORCID: 0009-0009-1588-5984
Observed ORCID: 0009-0009-1588-5984
OpenAlex ID: A5085970348
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020
2020 · Jianbin Li, Haibo Wang, et al. · EClinicalMedicine · 51
PDF
Expression of Rab5a correlates with tumor progression in pancreatic carcinoma
2017 · Yuandong Li, Xiaofang Sun, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 16
Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study
2022 · Haoqi Wang, Yuntao Li, et al. · Frontiers in Oncology · 15
PDF
Grape Seed Procyanidins Inhibit the Growth of Breast Cancer MCF-7 Cells by Down-Regulating the EGFR/VEGF/MMP9 Pathway
2021 · Fan-ting Kong, Chen-xi He, et al. · Natural Product Communications · 12
miR‑217‑5p suppresses epithelial‑mesenchymal transition and the NF‑κB signaling pathway in breast cancer via targeting of metadherin
2022 · Lixian Yang, Shuo Liu, et al. · Oncology Letters · 11
PDF
Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor–Positive and ERBB2 -Negative Advanced Breast Cancer After Endocrine Therapy: A Randomized Clinical Trial
2025 · Zhonghua Tao, Jian Zhang, et al. · JAMA Oncology · 6
PDF
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study
2025 · Lina Zhang, Yueping Liu, et al. · Breast Cancer Research · 6
PDF
Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
2021 · Jingping Li, Xiangmei Zhang, et al. · Medicine · 4
Compound 3d Attenuates Metabolic Dysfunction-Associated Steatohepatitis via Peroxisome Proliferator-Activated Receptor Pathway Activation and Inhibition of Inflammatory and Apoptotic Signaling
2025 · Shouqing Zhang, Jiajia Yu, et al. · Metabolites · 3
Neoadjuvant Anbenitamab and HB1801 in ERBB2 -Positive Breast Cancer: A Phase 3 Randomized Clinical Trial
2026 · Junjie Li, Tong Liu, et al. · JAMA Oncology · 2
PDF
Abstract PS8-06: A randomized, open-label phase III study comparing disitamab vedotin (an anti-HER2 monoclonal antibody-MMAE conjugate) with lapatinib plus capecitabine in patients with HER2-positive, advanced breast cancer with liver metastasis
2025 · Jiayu Wang, Quchang Ouyang, et al. · Clinical Cancer Research · 2
Abstract PS2-02: Tibremciclib (BPI-16350) plus fulvestrant versus placebo plus fulvestrant for patients with HR+/HER2- advanced breast cancer after progressing on endocrine therapy: Updated analysis of the phase III study
2025 · Zhonghua Tao, Jian Zhang, et al. · Clinical Cancer Research · 1
Abstract PO2-02-05: CDK4/6 inhibitor dalpiciclib combined with letrozole as neoadjuvant therapy in postmenopausal patients with hormone receptor-positive, HER2-negative stage II-III breast cancer: a single-arm exploratory trial
2024 · Lina Zhang, Chao Yang, et al. · Cancer Research · 1
A randomized trial of pegylated recombinant human granulocyte-colony stimulating factor to prevent febrile neutropenia in breast cancer after chemotherapy.
2022 · Lina Zhang, Yuntao Li, et al. · Journal of Clinical Oncology · 1
Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial
2026 · Jiayu Wang, Quchang Ouyang, et al. · Nature Communications
PDF
Updated survival outcomes of SYHX2011 versus albumin-bound paclitaxel in advanced breast cancer: A randomized double-blind phase III trial
2026 · Tiantian Tang, Jingxuan Wang, et al. · Biomolecules and Biomedicine
PDF
Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study
2026 · Lina Zhang, Jingxuan Wang, et al. · 癌症：英文版
Immunotherapeutic effects of 1-methyltroptophan combined with dendritic cells vaccine in mice with pancreatic carcinoma
2013 · Shu-bo Chen, Yuandong Li, et al. · Zhonghua shiyan waike zazhi
Relationship between serum adiponectin levels and clinicopahtological features of patients with breast cancer
2012 · Zhong Xiucai, Xiangshun Kong, et al. · Zhonghua shiyan waike zazhi
Works count: 19
Citation count: 131
H-index: 6
I10-index: 5
Year
Topic
Type